|Bid||61.51 x 900|
|Ask||61.76 x 1000|
|Day's range||61.22 - 62.00|
|52-week range||50.50 - 95.39|
|Beta (5Y monthly)||1.11|
|PE ratio (TTM)||215.67|
|Earnings date||02 May 2023 - 08 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||90.63|
Shares of Inari Medical (NASDAQ: NARI) were up 16.9% for the week as of late Thursday afternoon, according to data provided by S&P Global Market Intelligence. Several executives of the healthcare company increased their ownership stake in the company this week, including former CEO and current board member William Hoffman, CFO Mitch Hill, CEO Drew Hykes, and Chief Medical Officer Thomas Tu.
Inari Medical ( NASDAQ:NARI ) Full Year 2022 Results Key Financial Results Revenue: US$383.5m (up 38% from FY 2021...
Inari Medical's (NARI) fourth-quarter results benefit from significant progress made across all its growth drivers.